Search Results
Dec 04, 2025, 13:58 ET Fabrix.ai Showcases Enterprise-Grade Agentic AI Platform at "Agentic AI Unleashed" Summit
Cost tracking, usage analytics, and performance metrics as first-class telemetryIntelligent Digital Operators: SecOps agents, Digital SRE agents, and domain-specific autonomous workers with human-in-the-loop controlsOperational Runbooks: Prompt templates and persona-based
More news about: Fabrix.ai
Dec 04, 2025, 01:31 ET SDG&E® galardonada como la empresa de servicios públicos más confiable del oeste por vigésimo año consecutivo
Consulting por su extraordinario desempeño en materia de confiabilidad durante 20 años consecutivos. SDG&E es una filial de Sempra (NYSE: SRE), empresa estadounidense líder en infraestructuras energéticas. Para más información, visite
More news about: San Diego Gas & Electric (SDG&E)
Dec 03, 2025, 11:00 ET Honeycomb Signs Three-Year Strategic Collaboration Agreement with AWS to Accelerate AI Observability in the Enterprise
to improve performance, manage costs, and empower engineering teams to build and operate more resilient AI applications.Built for modern SRE practices: Engineering teams use Honeycomb to shorten incident response times, determine root cause across distributed systems, and ship changes
More news about: Honeycomb
Dec 02, 2025, 18:54 ET Accord Healthcare 宣佈推出 Denosumab∇ - 骨骼健康領域第二款生物相似藥
作為生物相似藥，可作為參考藥地諾單抗的臨床可互換替代品。JUBEREQ經證實與參照藥物地諾單抗具有生物等效性，在療效、安全性、藥代動力學特性或免疫原性方面均無臨床意義上的差異。相較於首次發生骨骼相關事件 (SRE) 前的生活品質狀態，轉移性前列腺癌患者在經歷 SRE 後於各項生活品質評分領域均呈現顯著下降。優於唑來膦酸 (zoledronic acid)，持續兩年以上有效預防骨骼相關事件發生，延遲首次事件發生時間腎功能障礙病人不需要調整劑量編輯備註：Osvyrti
More news about: Accord Healthcare
Dec 02, 2025, 18:16 ET Accord Healthcare annonce le lancement de son deuxième biosimilaire du denosumab dans le domaine de la santé osseuse
statut QVLS avant leur première complication osseuse (Skeletal-Related-Event, SRE), les patients atteints d'un cancer de la prostate métastatique ont présenté des améliorations marquées en termes de qualité de vie après un SRE.Prévention supérieure et durable des complications osseuses pendant
More news about: Accord Healthcare
Dec 02, 2025, 18:11 ET Accord Healthcare kündigt Einführung von Denosumab∇ an - zweites Biosimilar im Bereich Knochengesundheit
Wirksamkeit, Sicherheit, Pharmakokinetik oder ImmunogenitätIm Vergleich zu ihrem HRQOL-Status vor dem ersten SRE zeigten Patienten mit metastasierendem Prostatakrebs nach einem SRE deutliche Werte in allen Bereichen der Lebensqualität (Skeletal-Related-Events)Sehr lang anhaltende Prävention
More news about: Accord Healthcare
Dec 02, 2025, 17:53 ET Accord Healthcare anuncia o lançamento do Denosumabe∇ - Segundo Biossimilar em Saúde Óssea
significativas na eficácia, segurança, perfil farmacocinético ou imunogenicidadeEm comparação com seu estado de QVRS antes de sofrerem seu primeiro SRE, os pacientes com câncer de próstata metastático apresentaram pontuações significativas em todos os domínios da qualidade de vida após um ERE (Evento
More news about: Accord Healthcare
Dec 02, 2025, 17:50 ET Accord Healthcare anuncia el lanzamiento de Denosumab∇, segundo biosimilar en salud ósea
antes de experimentar su primer evento relacionado con el esqueleto (SRE, por sus siglas en inglés), los pacientes con cáncer de próstata metastásico mostraron puntuaciones marcadas en todos los dominios de calidad de vida después de un SREMejor prevención y más sostenida de eventos relacionados
More news about: Accord Healthcare
Dec 02, 2025, 17:45 ET 어코드 헬스케어, 두 번째 골다공증 바이오시밀러 제품인 데노수맙 출시
기존의 데노수맙 제품과 생물학적 동등성이 입증되었으며, 효능, 안전성, 약동학적 특성, 면역원성 측면에서 임상적으로 유의미한 차이가 없었다.환자가 처음으로 SRE(골격 관련 사건)를 겪기 이전의 건강 관련 삶의 질(HRQOL)과 비교했을 때, SRE 발생 후 모든 삶의 질 영역에서 점수가 현저히 높아진 것으로 확인되었다.졸레드론산과 비교했을 때, 뼈 질환과 관련해 2년 이상 지속되는 우수한 파급 효과 예방 효과를 발휘했으며, 첫 파급 효과 발생까지 걸리는 시간을 효과적으로 늦추었다.신장
More news about: Accord Healthcare
Dec 02, 2025, 17:30 ET SDG&E® Named Most Reliable Utility in the West for 20th Straight Year
ReliabilityOne® Award for Outstanding Reliability Performance for 20 consecutive years. SDG&E is a subsidiary of Sempra (NYSE: SRE), a leading North American energy-infrastructure company. For more information, visit
More news about: San Diego Gas & Electric (SDG&E)
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
profile or immunogenicityCompared to their HRQOL status before experiencing their first SRE, patients with metastatic prostate cancer showed marked scores across quality-of-life domains following an SRE (Skeletal-Related-Events)Superior, sustained prevention of skeletal related events for
More news about: Accord Healthcare
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
profile or immunogenicityCompared to their HRQOL status before experiencing their first SRE, patients with metastatic prostate cancer showed marked scores across quality-of-life domains following an SRE (Skeletal-Related-Events)Superior, sustained prevention of skeletal related events for
More news about: Accord Healthcare
Nov 24, 2025, 16:12 ET Sempra recognized among 'America's Best Employers for Company Culture' by Forbes
Sempra (NYSE: SRE) today announced it has been named one of "America's Best Employers for Company Culture" by Forbes, recognition that reflects the company's commitment
More news about: Sempra
Nov 24, 2025, 09:00 ET Observe, Inc. Ranked Number #38 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™
data, it's understanding it. That's why we built Observe on an open O11y Data Lake, a Knowledge Graph that captures real-time system context, and an AI SRE agent to reason over it. Our customers are troubleshooting 10x faster while cutting costs by up to 60%. As systems become more dynamic and autonomous,
More news about: Observe, Inc.
Nov 20, 2025, 10:01 ET Capability Center Services Market Set to Surpass USD 403.22 Billion by 2032 as Global Enterprises Accelerate Digital, Cloud, AI & GBS Transformation | According to DataM Intelligence
cybersecurity, infrastructure services, enterprise platforms, and AI/data engineering-areas where GCCs have become global leaders. The shift toward hybrid cloud, SRE (Site Reliability Engineering), DevSecOps, and AI-native operations continues to strengthen this category.
More news about: DataM Intelligence 4 Market Research LLP
Nov 18, 2025, 13:36 ET SoCalGas Declares Preferred Dividends
the Year by the Los Angeles Chamber of Commerce for its volunteer leadership in the communities it serves. SoCalGas is a subsidiary of Sempra (NYSE: SRE), a leading North American energy infrastructure company. For more information, visit
More news about: Southern California Gas Company
Nov 17, 2025, 10:00 ET AlertD Launches Multi-Purpose AI Agentic SRE and DevOps Platform to Transform Cloud Operations
to fundamentally transform the lives of SRE and DevOps teams. The name 'AlertD' pays homage to the Unix daemon ('d')—the silent processes that power critical infrastructure. The company's vision is to build a suite of specialized AI SRE and DevOps agents that are always available,
More news about: AlertD
Nov 12, 2025, 09:00 ET Deductive AI Formally Launches with $7.5M Funding to Deliver AI SRE Agents That Cut Incident Resolution Time by up to 90%
Founded by Databricks and ThoughtSpot veterans, Deductive AI introduces a new generation of AI SRE agents that accelerate root cause analysis and remediation, helping fast-moving engineering teams stay focused on building rather than firefighting.
More news about: Deductive AI
Nov 06, 2025, 19:41 ET Sempra Declares Common Dividend
Sempra (NYSE: SRE) today announced that its board of directors has declared a $0.645 per share quarterly dividend on the company's common stock, which is payable Jan.
More news about: Sempra
Nov 06, 2025, 07:48 ET DXC reconhecida como líder no estudo ISG Provider Lens® AWS Ecosystem Partners
em AWS, ultrapassando o suporte tradicional para oferecer plataformas inteligentes e resilientes, integrando operações orientadas por IA e princípios SRE (SIte Reliability Engineering) com soluções de gerenciamento de ambientes multicloud e soberanos", afirmou John Boccuzzi, Jr., presidente da ISG.
More news about: DXC Technology Company
Nov 06, 2025, 07:45 ET DXC es nombrada líder en el estudio ISG Provider Lens® AWS Ecosystem Partners
al ir más allá del soporte tradicional para ofrecer plataformas inteligentes y resilientes, e integrar operaciones impulsadas por IA y principios de SRE con soluciones multinube y de gestión de entornos soberanos", señaló John Boccuzzi, Jr., presidente de ISG. El estudio ISG Provider
More news about: DXC Technology Company
Nov 06, 2025, 01:44 ET DXC nombrada líder en el estudio ISG Provider Lens® sobre socios del ecosistema de AWS
AWS al ir más allá del soporte tradicional para ofrecer plataformas inteligentes y resilientes, integrando operaciones basadas en IA y principios de SRE con soluciones de gestión de entornos multicloud y soberanos", afirmó John Boccuzzi, Jr., presidente de ISG. El estudio ISG Provider
More news about: DXC Technology Company
Nov 06, 2025, 01:24 ET DXC wird in der Studie über AWS-Ökosystempartner von ISG Provider Lens® als einer der führenden Anbieter genannt
neu, indem es über den traditionellen Support hinausgeht und intelligente, widerstandsfähige Plattformen bereitstellt, die KI-gesteuerte Abläufe sowie SRE-Prinzipien mit Multi-Cloud- und souveränen Umgebungsmanagementlösungen integrieren", so John Boccuzzi Jr., Präsident bei ISG. Die
More news about: DXC Technology Company
Nov 06, 2025, 01:18 ET DXC est nommé leader dans l'étude ISG Provider Lens® AWS Ecosystem Partners
au-delà du support traditionnel pour fournir des plateformes intelligentes et résilientes, en intégrant des opérations pilotées par l'IA et des principes SRE avec des solutions de gestion d'environnements multicloud et souverains », a déclaré John Boccuzzi, Jr, président chez ISG. L'étude
More news about: DXC Technology Company
Nov 05, 2025, 08:03 ET SAS predictions: The Great AI Reality Check of 2026
multi-step customer interactions. These agents won't just advise, they'll execute, with measurable revenue impact. That will also create new roles like Agent SRE and even Chief Agent Officer. The flip side is that the first major "agent outage" will hit headlines, as organizations discover that when autonomous
More news about: SAS